123018-62-2 Usage
Description
4,4-Di-N-propylcyclohexanone is a clear, colorless liquid with unique chemical properties that make it a valuable compound in the pharmaceutical industry. It is primarily utilized in the synthesis of N-substituted phenylacetamide derivatives, which are known for their therapeutic effects on pain and inflammation.
Uses
Used in Pharmaceutical Industry:
4,4-Di-N-propylcyclohexanone is used as a key intermediate compound for the preparation of N-substituted phenylacetamide derivatives. These derivatives serve as therapeutic agents for the treatment of pain and inflammation, making them essential in the development of medications aimed at alleviating these conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 123018-62-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,3,0,1 and 8 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 123018-62:
(8*1)+(7*2)+(6*3)+(5*0)+(4*1)+(3*8)+(2*6)+(1*2)=82
82 % 10 = 2
So 123018-62-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H22O/c1-3-7-12(8-4-2)9-5-11(13)6-10-12/h3-10H2,1-2H3
123018-62-2Relevant articles and documents
N-SUBSTITUTED PHENYLACETAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
-
Page/Page column 70-71, (2008/06/13)
A compound represented by the formula: (I) wherein R1 represents a methoxy group, a hydroxyl group or a hydrogen atom; R2 represents a hydrogen atom, a C1-4 alkyl group, a C1-4 alkylcarbonyl group or an arylcarbonyl group; and D represents a group represented by the formula (A), (B) or (C) below. (A) (B) (C) This compound is useful as a therapeutic agent for a pain or inflammation induced by any one of various morbid conditions such as neuropathic pain, rheumatoid arthritis and osteoarthritis.
Immunomodulatory azaspiranes
-
, (2008/06/13)
A pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and an effective amount of an azaspirane derivative, a method of treating an animal in need of immunomodulation which comprises administering to such animal an effective amount of an azaspirane derivative, and certain azaspirane derivatives.